{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:35:55Z","timestamp":1791434155905,"version":"4.3.3"},"reference-count":13,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2024,5,10]]},"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/sextrans-2024-056165","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:21:21Z","timestamp":1716484881000},"page":"337-338","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["<i>Primum non-nocere<\/i>: Is it time to stop screening for<i>Neisseria gonorrhoeae<\/i>and<i>Chlamydia trachomatis<\/i>in men who have sex with men taking HIV pre-exposure prophylaxis?"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5541-6041","authenticated-orcid":false,"given":"Thibaut","family":"Vanbaelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2557-8998","authenticated-orcid":false,"given":"Chris","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2024081910400983000_100.6.337.1","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1016\/S1473-3099(23)00356-0","article-title":"Frequent screening for asymptomatic Chlamydia and Gonorrhoea infections in men who have sex with men: time to re-evaluate","volume":"23","author":"Williams","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024081910400983000_100.6.337.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100743","article-title":"Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach","volume":"34","author":"Kenyon","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2024081910400983000_100.6.337.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248582","article-title":"Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to re-evaluate STI-screening as a control strategy","volume":"16","author":"Marcus","year":"2021","journal-title":"PLoS One"},{"key":"2024081910400983000_100.6.337.4","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/S2352-3018(23)00299-0","article-title":"Effect of screening for Neisseria Gonorrhoeae and Chlamydia Trachomatis on incidence of these infections in men who have sex with men and Transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, Multicentre, controlled trial","volume":"11","author":"Vanbaelen","year":"2024","journal-title":"Lancet HIV"},{"key":"2024081910400983000_100.6.337.5","doi-asserted-by":"publisher","DOI":"10.1071\/sh15175"},{"key":"2024081910400983000_100.6.337.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31816-6"},{"key":"2024081910400983000_100.6.337.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4316","article-title":"Effectiveness of yearly, register based screening for Chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation","volume":"345","author":"van den Broek","year":"2012","journal-title":"BMJ"},{"key":"2024081910400983000_100.6.337.8","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000824"},{"key":"2024081910400983000_100.6.337.9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/09564624211025940","article-title":"Screening for Stis is one of the main drivers of macrolide consumption in prep users","volume":"32","author":"Vanbaelen","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2024081910400983000_100.6.337.10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as major Disruptors of gut Microbiota","volume":"10","author":"Ramirez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2024081910400983000_100.6.337.11","unstructured":"De I , Cuylaerts V , Smet H , et al . Neisseria Gonorrhoeae antimicrobial resistance surveillance report of Belgium \u2013 2022. In: National Reference Centre of Sexually Transmitted Infections (NRC-STI), Institute of Tropical Medicine. Antwerp, Belgium, 2022."},{"key":"2024081910400983000_100.6.337.12","unstructured":"Smet H , Kehoe K , et al . Estimation of the real magnitude of antimicrobial resistance of\u00a0Mycoplasma genitaliumin Belgium by implementing a prospective surveillance programme. 2023."},{"key":"2024081910400983000_100.6.337.13","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004273680"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2024-056165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T17:40:20Z","timestamp":1724089220000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2024-056165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8,19]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/sextrans-2024-056165"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2024-056165","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}